"Tech Prophet" Who Predicted the iPhone Now Predicts...
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Shares Stats
| Shares Outstanding | 3,159,200,000 |
| Shares Float | 3,159,190,000 |
| Shares Short | 8,870,000 |
| Insider Holdings | 1% |
| Institution Holdings | 2.72% |
About Takeda Pharmaceutical Co ADR
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.
General
| Name | Takeda Pharmaceutical Co ADR |
| Ticker | TAK |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Currency | USD |
| Country | USA |
| Fiscal Year End | March |
| Full Time Employees | 47,455 |
Highlights
| Analyst Target | 16.29 |
| Market Cap | 44,449,900,000 |
| PE Ratio | 178.55 |
| PEG Ratio | 0.29 |
| EBITDA | 1,138,373,033,984 |
Financials
| Profit Margin | 0.87% |
| Operating Margin | 11.06 |
| Return on Assets | 0.02 |
| Return on Equity | 0.00 |
| Revenue | 29.6B |
| Earnings Per Share | 0.07 |
| Revenue Per Share | 1,400.91 |
| Gross Profit | 2,862,113,882,112 |
| Quarterly Revenue Growth | -0.05 |
Valuation
| Trailing PE | 201 |
| Forward PE | 9.29 |
| Price/Sales (Trailing 12 Mt.) | 0.01 |
| Price/Book (Most Recent Quarter) | 0.97 |
Dividend
Takeda Pharmaceutical Co ADR pays out a dividend of $0.66 per share, with a dividend yield of 4.67%.
TAK's last dividend payment was made to shareholders on July 7, 2025.
They pay out 242.25% of their earnings out as a dividend.
Recent Dividends
| Dec 31, 1969 | $0.32 |
| Jul 7, 2025 | $0.34 |
| Dec 12, 2024 | $0.33 |
| Jul 8, 2024 | $0.30 |
Trump Clash Looms Over Zohran Mamdani's NYC Agenda
Zohran Mamdani readies legal, fiscal defenses as Trump threatens funding cuts, enforcement pressure and troop deployments targeting New York City.
Can Bitcoin Crash To $10,000? Yes, If It Follows This 2018 Pattern, Expert Says
Bitcoin (CRYPTO: BTC) is back under pressure as Bloomberg's Mike McGlone warns the market could unwind all the way to $10,000.
America's Defense Future Starts Underground - Ad
A N. American metals project just caught the attention of Rio Tinto - a mining giant. With four projects in key regions, this firm is aligned with Washington's push to rebuild the defense-metal supply chain.
Trump Promises $2000 'Tariff Dividend' Payout By Mid-2026, But Prediction Markets Remain Skeptical
Even though President Donald Trump has promised the $2,000 "tariff dividend" checks by mid-2026, prediction markets are skeptical.
Trump's China Tariff U-Turn, Ray Dalio's 'Melt-Up' Warning And More: This Week In Economy
Weekend roundup: Trump's China tariff shift, $17T investment claim, Dalio warns of market melt-up, shutdown hits GDP, Schiff weighs in on Supreme Court review.
From Strong to Stunning: New Drill Hole Sets a New Bar - Ad
Earlier holes showed 2.4% and 2.7% CuEq. This new hit just delivered 6.93% over nearly 20 metres. That's a game-changer - and it comes with deep insider alignment and an active program.
Donald Trump's 50-Year Mortgage Plan Could Redefine Homeownership In America — Housing Chief Calls It 'Game Changer' Amid Rising Costs
Trump admin considers 50-year mortgage plan to make homeownership more affordable. Critics warn it may inflate interest payments, reward banks
This Inexpensive Tesla Rival Is Quietly Gaining Ground — Key Ranking Suggests A Major Breakout Could Be Imminent
Li Auto surges into the top 10th percentile value ranking, up 1.30 points. Undervalued Tesla rival with moderate growth.
Forget Tesla - This Tiny AI Stock Is Musk's Real Play - Ad
Elon Musk's 750,000 sq ft AI facility in Memphis could be more lucrative than Tesla and SpaceX combined. NVIDIA is quietly investing- And we found a "backdoor" play for everyday investors.
Peter Schiff Says Bitcoin At $100K Is 'Incredible Opportunity' That Must Not Be Missed: 'If You Own Bitcoin, Hurry And…'
Peter Schiff, a vocal critic of the top cryptocurrency, has weighed in on Bitcoin (CRYPTO: BTC) reaching the $100,000 mark.
PwC Drops Millions On Palantir Partnership To Boost Britain's AI Push
PwC UK and Palantir have expanded their partnership, with PwC investing millions to deepen collaboration on AI solutions for key industries.
Trump Signs Law to Launch Dollar 2.0 - Ad
Trump just signed law S.1582, unleashing the biggest money shift in 100+ years. For the first time since 1913, private firms - not the Fed - can mint a "Dollar 2.0." Treasury says it could drain $6.6T from banks and pay 10X current savings rates. Early investors in minting firms could see 40X returns by 2032.
Sarepta Shares Jump After FDA Approves Updated Elevidys Label
Sarepta Therapeutics shares jumped after the FDA issued a new boxed warning for Elevidys.
'Rich Dad Poor Dad' Author Robert Kiyosaki Warns Of Crash In BTC, ETH, Gold, Silves Prices, But Says He's Buying, Not Selling: Here's Why
Robert Kiyosaki, author of “Rich Dad Poor Dad,” has shared his investment strategy amid predictions of an economic downturn.
Trump's Hidden Fed Agenda - Ad
Trump's latest moves show he's preparing to reshape the Federal Reserve - and the value of the U.S. dollar. With key appointees already in place, the coming monetary reset could send gold soaring like it did in the 1970s, when it climbed 24X in under a decade.
Asian shares retreat in cautious trading ahead of Nvidia profit report
TOKYO (AP) — Asian shares retreated in cautious trading Wednesday ahead of an earnings report from that is seen as a bellwether for the recent craze for artificial intelligence technology.
Apple Beats Earnings, $1 Billion Google AI Deal, Budget Mac And More: This Week In Appleverse
Apple had a busy week with earnings beats, AI partnerships, new product plans, and reflections on Steve Jobs' legacy.
Gold Near $4,073. Copper Tight. This Drill Hit Came Just in Time. - Ad
Dual exposure to two surging metals, plus 17.91% CuEq over mineable width, and infrastructure on site - this is what juniors dream of. And the market is just starting to notice.
Billie Eilish Asks Zuckerbeg, Other Billionaires To Donate
Billie Eilish urges billionaires to share their wealth for good causes during award acceptance speech. Mark Zuckerberg in attendance.
Peter Lynch on AI Stocks: 'I Literally Couldn't Pronounce Nvidia Until About Eight Months Ago'
Peter Lynch has stated that he does not hold any artificial intelligence (AI) stocks, despite the sector's recent surge.
Metals... Not Missles... Is the New Arms Race - Ad
China and Russia control 70% of the world's critical minerals, giving them leverage over the West. One N. American discovery could help shift that balance by developing the metals essential for defense systems.
Trump's White House Bathroom Renovation Sparks Fury, Economist Slams 'Clearly Wrong' Inflation Data And More: This Week In Economy
Week economy roundup: From inflation debates and White House renovations to job declines, stock surges, and Fed rate cuts.
Bitcoin, Ethereum, XRP, Dogecoin Fall As 'Fear' Sentiment Persists: Analyst Says BTC Will Be In 'Good Territory' For New High In November If...
Leading cryptocurrencies dive while stock futures rose on Sunday, in the wake of the U.S.-China trade truce.
Crypto Set to Skyrocket? (Do This Now!) - Ad
Biden-era crackdowns failed. Under Trump, crypto is entrenched with a Strategic Bitcoin Reserve, a pro-crypto SEC chair, and lawsuits dropped. Bitcoin, Ethereum, Ripple, and Solana have surged. A new law could open a $19T crypto boom, with ways to benefit without buying coins.
Palantir, Kimberly-Clark, Hims & Hers, Navitas And Cipher Mining: Why These 5 Stocks Are On Investors' Radars Today
PLTR, KMB, HIMS, NVTS, CIFR were among the stocks seen trending among investors on Monday, Nov. 3, 2025.
These are the 37 donors helping pay for Trump's $300 million White House ballroom
WASHINGTON (AP) — President Donald Trump says his $300 million White House ballroom will be paid for “100% by me and some friends of mine.”
All 4 Major Banks Race to Adopt 'Trump Dollars' - Ad
JPMorgan Chase, Bank of America, Wells Fargo, and Citigroup are all rushing to adopt a new, upgraded version of the U.S. dollar that President Trump authorized this past summer. But acclaimed analyst, Louis Navellier, believes this isn't just a minor upgrade - it's a complete transformation to American money.
Can Solana Do What Bitcoin Can't? Amplify's New ETF Aims For 36% Income
Amplify ETFs, the issuer known for thematic and income-driven fund products, has just launched the Amplify Solana 3% Monthly Option Income ETF (BATS:SOLM), a first-of-its-kind product combining the growth momentum in Solana (CRYPTO:
Why Is Trump Memecoin Soaring As Bitcoin, Ethereum Tumble?
The Official Trump (CRYPTO: TRUMP) memecoin erupted into a double-digit rally on Wednesday amid reports that the project's issuer is in talks to buy crowdfunding platform Republic.
"Tech Prophet" Who Predicted the iPhone Now Predicts... - Ad
George Gilder - who predicted the iPhone 17 years early and gave Reagan the first microchip - is making his boldest call yet. He says an American nanotech "super-convergence" could mint more millionaires than any event in recent memory. He's found 3 stocks set to benefit before November 18's bombshell.
Jim Cramer: Chipotle Is 'Too Expensive,' Buy This Plane Maker
On "Mad Money," Cramer discusses Henry Schein, Bloom Energy, Tyler Technologies, Boeing and Chipotle Mexican Grill.
Peter Thiel Once Explained Why Bitcoin Won't Go Up 'Dramatically' And How It's Set For A 'Volatile, Bumpy Ride' Thanks To BlackRock
Bitcoin's ongoing struggles have brought renewed attention to comments made last year by Palantir Technologies co-founder Peter Thiel, who predicted that the leading cryptocurrency was unlikely to see a dramatic surge
America's Defense Future Starts Underground - Ad
A N. American metals project just caught the attention of Rio Tinto - a mining giant. With four projects in key regions, this firm is aligned with Washington's push to rebuild the defense-metal supply chain.
Coeur Mining's $7 Billion Deal For New Gold Creates $20 Billion Powerhouse
Coeur Mining Inc. (CDE) announced acquisition of New Gold Inc. (NGD) in all-stock deal valued at $7 billion.
Indians who fled a Myanmar cyberscam center are being flown home from Thailand
MAE SOT, Thailand (AP) — is repatriating on Thursday the first batch of hundreds of its nationals who last month fled to Thailand from Myanmar, where most had been working at a .
From Strong to Stunning: New Drill Hole Sets a New Bar - Ad
Earlier holes showed 2.4% and 2.7% CuEq. This new hit just delivered 6.93% over nearly 20 metres. That's a game-changer - and it comes with deep insider alignment and an active program.
Warren Buffett Opens Up About The Biggest Investing Blunders Of His Career — Here They Are
Over the decades, the "Oracle of Omaha" has shared candid reflections on his biggest blunders, from emotional decisions to missed opportunities, all of which provide timeless investing insights.
Trump's 50-Year Mortgage Plan, Sanders Critiques Musk, Trump Backs Crypto And More: This Week In Politics
Weekend headlines: Trump's 50-year mortgage plan, Sanders criticizes Musk, Trump backs crypto, Scaramucci on NYC mayor, Mamdani challenges Trump.
Forget Tesla - This Tiny AI Stock Is Musk's Real Play - Ad
Elon Musk's 750,000 sq ft AI facility in Memphis could be more lucrative than Tesla and SpaceX combined. NVIDIA is quietly investing- And we found a "backdoor" play for everyday investors.
Roblox steps up age checks and groups younger users into age-based chats
Roblox is stepping up its age verification system for users who want to privately message other players and implementing age-based chats so kids, teens and adults will only be able to message people around their own age.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.